Dr. Fang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-590-1751- Is this information wrong?
Education & Training
- University at BuffaloResidency, Pathology-Anatomic and Clinical, 1998 - 2003
- Sun Yat-Sen University of Medical ScienceClass of 1983
Certifications & Licensure
- TX State Medical License 2009 - 2024
- NY State Medical License 2003 - 2015
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Sor...> ;Nature Communications. 2024 Mar 13
- 1 citationsDeep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images.Wen, Z., Luo, D., Wang, S., Rong, R., Evers, B., Jia, L., Fang, Y., Daoud, E., Yang, S., Gu, Z., Arner, E., Lewis, C., Solis Soto, L., Fujimoto, J., Behrens, C., Wistu...> ;Modern Pathology. 2024 Feb 1
- Protein arginine methyltransferase 5 (PRMT5) is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Sor...> ;Research Square. 2023 Jul 10
- Join now to see all
Hospital Affiliations
- University of Texas Southwestern Medical CenterDallas, Texas
- Parkland HealthDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: